Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction

被引:98
作者
Konakova, M
Hucho, F
Schleuning, WD
机构
[1] Schering AG, Inst Mol & Cellular Biol, Res Labs, D-13342 Berlin, Germany
[2] Free Univ Berlin, Inst Biochem, D-1000 Berlin, Germany
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1998年 / 253卷 / 02期
关键词
plasminogen activator; urokinase-type-plasminogen-activator receptor; Src-type kinase; mitogen-activated protein kinase; signal transduction;
D O I
10.1046/j.1432-1327.1998.2530421.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have investigated cellular signalling events induced by urokinase-type plasminogen activator (uPA) independent of its proteolytic activity. Treatment of the human fibrosarcoma cell line HT 1080 with diisopropylphosphorofluoridate-inactivated uPA (Dip-F-uPA) triggers a cascade of intracellular signals which are mediated by the specific cell surface receptor for uPA (uPAR). We have found that anti-uPAR Ig precipitate the src-type protein tyrosine kinases fyn, hck and lck, which belong to a family of structurally and functionally related effectors participating in signalling from antigen and cytokine receptors. Of the three uPAR-associated kinases, only hck is activated by uPA, whereas no changes in the activities of either fyn or lck could be detected by an in vitro immune complex kinase assay. We identified p38 and extracellular-signal-regulated kinase 2 from the mitogen-activated protein kinase family as downstream components of a set of consecutive signalling molecules which teleologically alter the program of gene expression. Exposure of cells to uPa results in a significant increase in c-fos mRNA that is partially due to an elevated rate of gene transcription. Presumably the activation of the c-Sos gene leeds to the subsequent formation of the transcription factor activator protein-1 (AP-1), since accumulation of c-fos mRNA is followed by induction of target genes sensitive to AP-1 such as plasminogen activator inhibitor type 2 (PAI-2). These results provide new insights into proteolysis-independent cytokine-like effects of uPA.
引用
收藏
页码:421 / 429
页数:9
相关论文
共 50 条
  • [21] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN RABBIT TEARS - COMPARISON WITH HUMAN TEARS
    TOZSER, J
    BERTA, A
    EXPERIMENTAL EYE RESEARCH, 1990, 51 (01) : 33 - 37
  • [22] The diagnostic value of serum urokinase-type plasminogen activator receptor in acute appendicitis
    Aygun, Ali
    Gunaydin, Mucahit
    Ozozan, Omer Vefik
    Cihan, Murat
    Karakahya, Murat
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2019, 25 (05): : 467 - 473
  • [23] The role of urokinase-type plasminogen activator in the invasion and proliferation of malignant brain tumors
    Takano, S
    Yoshii, Y
    Nose, T
    Landau, B
    Brem, S
    BRAIN TUMOR: RESEARCH AND THERAPY, 1996, : 119 - 125
  • [24] LOCALIZATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITOR-1,2 AND PLASMINOGEN IN COLON-CANCER
    NAITOH, H
    EGUCHI, Y
    UEYAMA, H
    KODAMA, M
    HATTORI, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (01): : 48 - 56
  • [25] Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas
    Foca, C
    Moses, EK
    Quinn, MA
    Rice, GE
    GYNECOLOGIC ONCOLOGY, 2000, 79 (02) : 244 - 250
  • [26] Amiloride, a urokinase-type plasminogen activator receptor (uTPA) inhibitor, reduces proteinurea in podocytes
    Xu, L. B.
    Chi, N.
    Shi, W.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 9518 - 9529
  • [27] Radiometallated peptides targeting guanylate cyclase C and the urokinase-type plasminogen activator receptor
    Praharaj, Snigdha
    Overbey, Douglas
    Giblin, Michael F.
    FUTURE ONCOLOGY, 2010, 6 (08) : 1325 - 1337
  • [28] Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma
    Casella, R
    Shariat, SF
    Monoski, MA
    Lerner, SP
    CANCER, 2002, 95 (12) : 2494 - 2499
  • [29] MOLECULAR-CLONING OF CDNA FOR THE BOVINE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR
    REUNING, U
    LITTLE, SP
    DIXON, EP
    JOHNSTONE, EM
    BANG, NU
    THROMBOSIS RESEARCH, 1993, 72 (01) : 59 - 70
  • [30] Evaluation of urokinase-type plasminogen activator and its receptor in neointima of polyester vascular grafts
    Kowalewski, R
    Zimnoch, L
    Wojtukiewicz, MZ
    Glowinski, J
    Glowinski, S
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2005, 34 (01) : 23 - 28